Literature DB >> 6782928

Tocainide-associated interstitial pneumonitis.

G M Perlow, B P Jain, S G Pauker, H S Zarren, D C Wistran, R L Epstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6782928     DOI： 10.7326/0003-4819-94-4-489

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  4 in total

Review 1.  Adverse effects of class I antiarrhythmic drugs.

Authors:  J Caron; C Libersa
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

2.  Irreversible interstitial pneumonitis associated with tocainide therapy.

Authors:  B Van Natta; M Lazarus; C Li
Journal:  West J Med       Date:  1988-07

3.  Tocainide-associated interstitial pneumonitis.

Authors:  A C Braude; E Downar; D W Chamberlain; A S Rebuck
Journal:  Thorax       Date:  1982-04       Impact factor: 9.139

Review 4.  Tocainide. A review of its pharmacological properties and therapeutic efficacy.

Authors:  B Holmes; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-08       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.